Wednesday 22 May, 2019 04:25 AM
Site map | Locate Us | Login
   Tata Motors Ltd leads losers in 'A' group    Radha Madhav Corporation Ltd leads losers in 'B' group    Volumes soar at Thyrocare Technologies Ltd counter    United Breweries Ltd rises for third straight session    Jubilant Foodworks Ltd soars 1.29%, rises for fifth straight session    ICICI Lombard General Insurance Company Ltd rises for fifth straight session    Bajaj Finance Ltd extends gains     TVS Motor Company Ltd up for fifth straight session    BLB Ltd leads gainers in 'B' group    Just Dial Ltd leads gainers in 'A' group    Volumes soar at Jubilant Life Sciences Ltd counter    Tata Motors drops after weak Q4 result    Tata Motors Ltd Falls 5.21%, S&P BSE Auto index Drops 1.36%    Muthoot Capital Services Ltd Spurts 5.52%    Dr Reddys Laboratories Ltd leads losers in 'A' group 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Sun Pharma moves up after raising stake in Russia's PJSC Biosintez
14-Mar-19   14:57 Hrs IST

The announcement was made after market hours yesterday, 13 March 2019.

Meanwhile, the S&P BSE Sensex was down 15.60 points, or 0.04% to 37,736.57.

On the BSE, 7.36 lakh shares were traded in the counter so far compared with average daily volumes of 4.87 lakh shares in the past two weeks. The stock had hit a high of Rs 468.40 and a low of Rs 456.30 so far during the day. The stock hit a 52-week high of Rs 678.80 on 6 September 2018. The stock hit a 52-week low of Rs 375.40 on 18 January 2019.

Sun Pharmaceutical Industries said that its wholly-owned subsidiary has increased its shareholding in PJSC Biosintez, Russia, by purchasing 33,958 shares (30,221 ordinary shares and 3,737 preferred shares) equivalent to 11.86% of PJSC Biosintez under mandatory tender offer for $3.21 million. Post completion of this purchase of shares, the total holding of wholly owned subsidiary company increased from 85.10% to 96.96% in PJSC Biosintez.

On a consolidated basis, Sun Pharmaceutical Industries' net profit rose 310% to Rs 1,461.03 crore on 16.04% increase in net sales to Rs 7,656.71 crore in Q3 December 2018 over Q3 December 2017.

Sun Pharmaceutical Industries is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.G Anand , anand@ssplwealth.com
Hit Count : 11144922
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd